[HTML] Delivery of miR-212 by chimeric peptide-condensed supramolecular nanoparticles enhances the sensitivity of pancreatic ductal adenocarcinoma to …
W Chen, Y Zhou, X Zhi, T Ma, H Liu, BW Chen… - Biomaterials, 2019 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is a destructive cancer with poor prognosis. Both
novel therapeutic targets and approaches are needed to improve the overall survival of
PDAC patients. MicroRNA-212 (miR-212) has been reported as a tumor suppressor in …
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to >99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltd
www.pepmic.com
W Chen, Y Zhou, X Zhi, T Ma, H Liu, BW Chen… - Biomaterials, 2019 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is a destructive cancer with poor prognosis. Both
novel therapeutic targets and approaches are needed to improve the overall survival of
PDAC patients. MicroRNA-212 (miR-212) has been reported as a tumor suppressor in …
novel therapeutic targets and approaches are needed to improve the overall survival of
PDAC patients. MicroRNA-212 (miR-212) has been reported as a tumor suppressor in …
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltdeva@pepmic.com
www.pepmic.com
没有评论:
发表评论